Detalles de la búsqueda
1.
Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. Cancers 2022, 14, 1510.
Cancers (Basel)
; 15(5)2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900424
2.
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial.
Cancers (Basel)
; 14(6)2022 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326659
3.
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma.
Hemasphere
; 5(11): e656, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34901759
4.
NDR Kinases Are Essential for Somitogenesis and Cardiac Looping during Mouse Embryonic Development.
PLoS One
; 10(8): e0136566, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26305214
5.
NDR functions as a physiological YAP1 kinase in the intestinal epithelium.
Curr Biol
; 25(3): 296-305, 2015 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25601544
6.
The kinases NDR1/2 act downstream of the Hippo homolog MST1 to mediate both egress of thymocytes from the thymus and lymphocyte motility.
Sci Signal
; 8(397): ra100, 2015 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26443704
7.
hMOB3 modulates MST1 apoptotic signaling and supports tumor growth in glioblastoma multiforme.
Cancer Res
; 74(14): 3779-89, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24872389
Resultados
1 -
7
de 7
1
Próxima >
>>